NCT01759654View on ClinicalTrials.gov

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 24, 2012

Primary Completion Date

December 25, 2012

Study Completion Date

March 31, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

AdimFlu-V

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Adimmune Corporation

INDUSTRY

NCT01759654 - A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects | Biotech Hunter | Biotech Hunter